WeVote
Log In

Bill

Bill

HF 2699

Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated.

2025-2026 Regular Session Introduced by Alex Falconer and 7 co-sponsors

Minnesota bill legalizes psilocybin possession and cultivation for adults 21+, establishes regulatory board and harm reduction programs, while maintaining criminal penalties and federal conflict risk.

Introduction and first reading, referred to Health Finance and Policy
#drugsandmedicine
0
WeVote Research Nonpartisan
Bill Summary · HF 2699

Legislative bill overview

HF 2699 would legalize psilocybin (magic mushrooms) cultivation, possession, and personal use for adults 21 and older in Minnesota. The bill establishes a regulatory framework including a Psychedelic Medicine Board, public education programs, and harm reduction services, while maintaining criminal penalties for violations and allowing civil lawsuits.

Why is this important

This represents a significant shift in drug policy—moving psilocybin from Schedule I controlled substance to legal status for personal use. The bill reflects growing medical research on psilocybin's potential therapeutic benefits for depression, PTSD, and end-of-life anxiety, while raising questions about implementation, public safety, and federal-state legal conflicts.

Potential points of contention

  • Federal law conflict: Psilocybin remains a Schedule I controlled substance federally; state legalization creates legal ambiguity and potential enforcement complications
  • Regulatory uncertainty: The bill's specifics on cultivation limits, possession quantities, and enforcement mechanisms are not detailed in this summary, leaving implementation details unclear
  • Public health concerns: Critics may worry about youth access, impaired driving, workplace safety, and long-term cognitive effects, particularly for developing brains under age 25
  • Medical vs. recreational divide: Tension between framing this as therapeutic versus recreational use, and whether medical oversight is adequately addressed

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.